 |
   |
 |
|
|
Sign Up Today The Immune Disease eNewsletter gives you the latest updates. 
|
IVIG Therapy for PIGet IVIG SupportIf you have a primary immune deficiency (PI), you know how important it is to have access to the therapy you need and the brand that meets your unique requirements. If you move, change jobs, or lose your insurance coverage, maintaining access to your preferred IVIG therapy can be challenging. Baxter offers a number of programs that support your IVIG access. GARDian
Using a simple, voluntary enrollment process administered through patients’ healthcare providers, enrollees will have the comfort of knowing that GAMMAGARD LIQUID and GAMMAGARD S/D will be available to them today and tomorrow. Sign up to receive updates on the GARDian program . Other Baxter Support ProgramsGARDian is the latest in a series of support programs for patients who rely on GAMMAGARD LIQUID and GAMMAGARD S/D.
Have a Question ?
Find answers and submit questions on insurance, medical topics, and family issues at our PI Panel. IVIG Formulations
Learn about the various GAMMAGARD formulations Baxter offers for Primary Immune Deficiency. Patient Resources
Request helpful tools for patients who rely on IVIG. Insurance AssistanceFind out about Baxter's comprehensive support. GAMMAGARD LIQUID is indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. These include but are not limited to congenital X-linked agammaglobulinemia, common variable immunodeficiency, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies. Please see the Important Safety Information and Full Prescribing Information for GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10% GAMMAGARD S/D and GAMMAGARD S/D, IgA less than 1 µg/mL in a 5% solution are indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. These include but are not limited to congenital X-linked agammaglobulinemia, common variable immunodeficiency, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies. GAMMAGARD S/D must not be used in patients with selective IgA deficiency (IgA < 0.05 g/L) where the IgA deficiency is the only abnormality of concern. Please see the Important Safety Information and Full Prescribing Information for GAMMAGARD S/D [Immune Globulin Intravenous (Human)] Please see the Important Safety Information and Full Prescribing Information for GAMMAGARD S/D [Immune Globulin Intravenous (Human)], IgA less than 1 µg/mL in a 5% solution.  To view PDFs, you will need Adobe® Acrobat® Reader® software. |
GARDian is an innovative Baxter program designed to help ensure continued access to GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10% and GAMMAGARD S/D [Immune Globulin Intravenous (Human)] for current patients. Enrolling your patients in GARDian is a simple, secure way to ensure their continued access to GAMMAGARD, their choice of treatment, when they change physician, site of care, or residence.